Product Information
AMITRIPTYLINE HCL 150 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2973 per EA under NDC 16571011001. Its NADAC has been published 139 times since Nov 1, 2023.
Strength
150 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571011001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217411On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 150 MG TAB has been published 139 times since Nov 1, 2023, and over the history we have for it it has risen 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2973 per EA |
|---|---|
| All-time high | $0.3651 (Mar 13, 2024) |
| All-time low | $0.1849 (Mar 19, 2025) |
| 52-week high | $0.2973 |
| 52-week low | $0.1953 |
| Median price | $0.2457 |
| Average price | $0.2441 |
| Largest weekly change | +45.9% (Feb 21, 2024) |
| Weeks tracked | 139 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 150 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.2973 per EA (NDC 16571011001), effective Jun 24, 2026.
How has the price of AMITRIPTYLINE HCL 150 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has risen 13.1%. It has been tracked across 139 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 150 MG TAB?
Since Nov 1, 2023, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has ranged from a low of $0.1849 (Mar 19, 2025) to a high of $0.3651 (Mar 13, 2024), with a median of $0.2457 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 150 MG TAB?
8 NADAC-published products share the same active ingredient, strength, and dosage form as AMITRIPTYLINE HCL 150 MG TAB, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 150 MG TAB?
AMITRIPTYLINE HCL 150 MG TAB (NDC 16571011001) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification